NECTIN1 and cancer: As shown in Figure 1C, EV induced dose‐dependent inhibition of cell growth of NECTIN‐4 expressing cancer cells (LNCaP and 22Rv1), while NECTIN‐4‐negative PC‐3 cells were resistant to EV treatment (unpaired t‐test, p < 0.01).